Soliris 300 MG/30 ML vial 30ML
Ended Awarded
- Contract number
- SPE2DX25F6ACQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $30,136
Award facts
- Contract value 100% obligated
- $30,136.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On August 6, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $30,136.38 to DMS Pharmaceutical Group Inc. for the supply of Soliris 300 mg/30 ml vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this contract with an ultimate completion date of August 27, 2025. The award utilizes a firm fixed-price delivery order structure with no set-aside designation, allowing the company to compete directly in the federal procurement marketplace based on its established capabilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.99 billion vehicle valued through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. The contractor has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and specialty medications to military health systems. Soliris, a complement inhibitor used to treat rare blood disorders and certain eye conditions, represents one component of the extensive pharmaceutical portfolio supplied under this framework.
Quick answers
Who was awarded contract SPE2DX25F6ACQ?
SPE2DX25F6ACQ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 6, 2025.
How much is contract SPE2DX25F6ACQ worth?
The government has obligated $30,136 on SPE2DX25F6ACQ.
Is contract SPE2DX25F6ACQ an order under another contract?
Yes. SPE2DX25F6ACQ is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ACQ competed?
The extent of competition for SPE2DX25F6ACQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award